HONG KONG – A recent University of Hong Kong (HKU) study has discovered a novel non-antibiotic drug with potent efficacy against methicillin-resistant Staphylococcus aureus (MRSA), which represents a promising lead compound for development of anti-virulence drugs against S. aureus.